✦ LIBER ✦

Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients

✍ Scribed by Kuypers, D R J

Book ID: 109846016
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 81 KB
Volume: 88
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.2010.129

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to “Pharmacogenetic vs. Concent

Response to “Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients”

✍ Thervet, E 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

047 MYCOPHENOLATE ASSOCIATED DIARRHEA IN

047 MYCOPHENOLATE ASSOCIATED DIARRHEA IN RENAL ALLOGRAFT RECIPIENTS USING CONCENTRATION CONTROLLED DOSING

✍ VM Annapandian; G Basu; BS Mathew; K Saravanakumar; M Mohapatra; VG David; S Mad 📂 Article 📅 2011 🏛 Medknow Publications 🌐 English ⚖ 30 KB

A Comparative, Randomized Trial of Conce

A Comparative, Randomized Trial of Concentration-Controlled Sirolimus Combined With Reduced-Dose Tacrolimus or Standard-Dose Tacrolimus in Renal Allograft Recipients

✍ Bechstein, W.O.; Paczek, L.; Wramner, L.; Squifflet, J.-P.; Zygmunt, A.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 542 KB

European randomised trial of dual versus

European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients

✍ R.W.S. Chang; S. Snowden; A. Palmer; J.T.C. Kwan; M. Nicholson; S.H. Kashi; O.N. 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 606 KB

European randomised trial of dual versus

European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients

✍ René W. S. Chang; Susan Snowden; Andrew Palmer; Jonathan T. C. Kwan; Michael Nic 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 107 KB

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n